Publicerad: 2021-05-20 07:39 | Uppdaterad: 2021-05-20 07:44

Aktuella utlysningar, vecka 20, 2021

Grants Office tipsar om aktuella utlysningar.

Svenska och nordiska utlysningar

Odontology project grants - Eklund Foundation

Supports experimental or clinical studies in all fields of dentistry. Projects that relate to periodontology, implantology, and cariology will be prioritised.

Closing date: 31 May 2021

Further information

Forskningsanslag - ParkinsonFonden

Stöder svensk klinisk forskning om Parkinson. Anslag kan sökas för ett år i taget i följande kategorier, projektanslag (högsta belopp 500 000 kr), apparaturanslag (högsta belopp 300 000 kr) och reseanslag (högsta belopp för konferensresor är 10 000 kr inom Europa, 15 000 kr utom Europa (för forskningsvistelser är det maximala beloppet 30 000 kronor). Anslag kan endast sökas av den som har hel- eller deltidstjänst vid ett svenskt universitet eller sjukhus.

Closing date: 1 June 2021

Further information

Project support within radiation therapy research - Swedish Cancer Society

Supports research projects in radiation therapy with a focus on the treatment of cancer patients. Funding is worth 2 - 10 million SEK per year for three to five years.

Closing date: 16 August 2021

Further information

Familjen Kamprads stiftelse: Entreprenörskap för en levande landsbygd

Familjen Kamprads stiftelse utlyser i år projektanslag inom området ”Entreprenörskap för en levande landsbygd”. Årets utlysning öppnar den 30 augusti.

Closing date: Steg 1 öppnar den 30 augusti 2021 och stänger den 30 september 2021 kl. 16.00.

Further information

Utlysning av medel för alkoholforskning

Systembolagets Alkoholforskningsråd delar årligen ut anslag till olika forskningsprojekt. Samhällsvetenskaplig och medicinsk alkoholforskning stöds, forskning som är av särskild betydelse för det förebyggande arbetet mot alkoholskador prioriteras. Tio miljoner kronor delas ut varje år. Av dessa är två miljoner avsatta för av Systembolaget identifierade fokusområden och två miljoner kronor är avsatta till ansökningar från juniora forskare

Closing date: 15 September 2021

Further information

Europeiska utlysningar

ERC-2021-AdG Advanced Grants -- Horizon Europe: Excellent Science, EU and other funders

These support established, leading principal investigators who want long-term funding to pursue a ground-breaking, high-risk project. Applicants should be exceptional leaders in terms of originality and significance of their research contributions, with a track record of significant research achievements in the last ten years.  Applications may be made in any field of research, with an emphasis on the frontiers of science, scholarship and engineering.

Advanced Grants may be awarded up to €2.5 million for a period of 5 years, though an additional € 1 million can be made available under certain circumstances.

If you are interested in applying for an ERC Advanced Grant with KI as host institution, please contact KI Grants Office for further information.

Closing date: 31 August 2021

Further information

Marie Skłodowska-Curie Actions (MSCA) Upcoming Postdoctoral Fellowships 2021
The MSCA 2021

Postdoctoral Fellowships program is preliminarily scheduled to open at the end of May. You can do a postdoc either within Europe with a 2-year fellowship (European Fellowship), or outside Europe (2 years) with a mandatory 1-year return phase to Europe with the 3-year Global Fellowship.

Closing date: 15September 2021 (Preliminary)

Further information

Grants Office organizes an information webinar aimed at KI employees and KI associated researchers, as well as researchers who plan to apply with KI as host organization. Read more about the information webinar and register 

Advanced research grants in amyotrophic lateral sclerosis -- Radala Foundation for ALS Research, CH

These support potentially ground-breaking, high-risk projects in basic research in ALS. Grants are for studies of the understanding of the basic causes of the disease, and clinically related projects for patient care are not eligible.

Established, leading PIs may apply. They are expected to be active researchers and have a track-record of significant research achievements in the last 10 years. Research must be conducted in a public or private research organisation. There are no geographical limitations.

Up to two grants are available, each worth CHF 200,000 over two years.

Closing date: 30 June 2021. This call is repeated 2 times a year.

Further information

EFSD/JDRF/Lilly European programme in type 1 diabetes research grants --European Association for the Study of Diabetes, EUR

These aim to promote the highest quality of basic and clinical biomedical research, expedite the practical application of scientific advances, encourage clinical translational research and increase awareness of type 1 diabetes. Projects may be within any area of basic or clinical research related type 1 diabetes, including treatment and monitoring.

Applications are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. Grants are worth up to €100,000 for a minimum period of one year.

Closing date: 1 July 2021

Further information

Early detection and diagnosis project award -- Cancer Research UK, GB

This supports research projects that drive a transformational change in how and when early cancers and pre-cancerous states are diagnosed. Projects should aim to detect and diagnose consequential precancerous changes and cancer at the earliest possible point at which an intervention might be made, reducing the burden of late-stage disease

Scientists, clinicians and healthcare workers in UK universities, medical schools, hospitals, CRUK institutes and other research institutions may apply. Multi-institutional proposals are welcome and international and commercial organisations may be included as co-applicants or collaborators.

Awards are worth up to £500,000 each for up to three years, or four years when funding a PhD.

Closing date: 15 July 2021. This call is repeated 3 times a year.

Further information

Networking project grants -- European Society for Paediatric Gastroenterology, Hepatology and Nutrition, EUR

These enable members to undertake research activities and network among centres at an international level. Activities may include interactive educational events and clinical networks. Proposals relevant to the society’s activities, such as the validation of guidelines, or clinical networks for testing treatment regimes or disease management, are encouraged.

Main applicants must be members of the society and all projects must include more than one country. Non-society members may participate in collaboration with society members.

Five grants, worth up to €50,000 each, are available.

Closing date: 31 July 2021

Further information

Amerikanska utlysningar

Federal Funding agencies

Processing and Presentation of Non-Conventional MHC Ligands (R01, R21 Clinical Trial Not Allowed), NIH

This Funding Opportunity Announcement (FOA) invites applications to characterize antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands presented by classical and non-classical MHC class I and class II molecules, and to determine the contribution of these unique antigenic ligands to: protective immune responses to infectious pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or in the induction/progression or prevention of immune-mediated diseases. These studies may facilitate the development of novel tools and reagents to advance design of immune-based therapeutics and vaccines.   

This funding opportunity uses the NIH research project (R01) grant mechanism and runs in parallel with one of similar scientific scope, PA-19-066, which solicits applications under the NIH exploratory/developmental (R21) grant mechanism.

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-19-067 (R01), PA-19-066 (R21)

Further information (R01)

Further information (R21)

HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed), NIH

The goals of this Funding Opportunity Announcement (FOA) are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral suppression and antiretroviral therapy. In addition, FOA also encourages research studies to aid in the identification/ validation of biomarkers and pre-clinical targets with quantifiable readouts in domestic and international settings. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Closing date: September 7, 2021 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-20-149 

Further information 

New computational methods for understanding the functional role of DNA variants that are associated with mental disorders (R01 clinical trial not allowed), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to support the development of advanced computational, bioinformatic and statistical tools to determine the functional relevance of genetic variants associated with mental disorders of complex etiologies identified through genome-wide association or sequencing studies. The overarching goal of this initiative is to support the development of innovative computational methods that facilitate the elucidation of the functionality of genetic variants associated with mental illness, taking into account the added complexities and nuances of brain diseases, and to ultimately inform novel treatment development based on human biology.

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-18-908

Further information 

 

Foundations

Irvington postdoctoral fellowships, Cancer Research Institute, US

The Cancer Research Institute invites applications for the Irvington postdoctoral fellowships. These support young scientists at universities and research centres worldwide who wish to receive training in cancer immunology. Projects should be hypothesis driven, mechanistic studies in both immunology and tumour immunology that directly impact understanding of the immune system’s role in cancer.

Eligibility: Applicants must have a doctoral degree and less than five years’ relevant postdoctoral experience, with the exception of MD applicants. They must be working in areas directly related to immunology or cancer immunology Projects must be conducted under a sponsor who holds a formal appointment at the host institution. The fellowship may be taken in the US or abroad, but must be conducted at a non-profit institution. There are no citizenship restrictions.

Budget: Fellowships are worth USD 175,500 each over three years. Funding may cover salary, health insurance, travel expenses and other research-related costs.

Closing date: October 1, 2021 by 5 p.m. Eastern Time

Further information 

Technology impact award, Cancer Research Institute, US

The Cancer Research Institute invites applications for its technology impact award. This supports the development of innovative technologies that can lead to the next generation personalised cancer immunotherapies. This programme aims to encourage projects that generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modelling systems, immunological or tumour profiling instrumentation, methods, reagents and assays or other relevant technologies that can help clinician scientists gain deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies. Proposals should address areas where technological innovation stands to benefit the field and cancer patients most, including the following focus areas:

  • new bioinformatics methods or technologies that speed collection and analysis of large sets of patient-derived biological data;
  • computer simulations to model biological systems and responses to immunotherapy;
  • tools and methods that improve profiling of tumours to inform therapeutic strategies;
  • real-time visualisations of molecular and cellular activity to improve tracking of responses to immunotherapy;
  • in vitro tissue culture systems that recapitulate the interactions between primary tumour cells and the immune system.

Eligibility: Applications are open to individual investigators leading a cross-functional team. They must hold a faculty appointment as a tenure-track assistant professor, or higher rank, at the time of award activation.

Budget: Grants are worth up to USD 200,000 each for between one and two years.

Closing date: Letters of Intent describing the research plan will be submitted electronically by November 15, 2021; Selected applicants will be invited to submit a full research proposal with a submission deadline of March 15, 2022.

Further information